• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛癌分析的蛋白质基因组学数据和资源。

Proteogenomic data and resources for pan-cancer analysis.

机构信息

Department of Medicine, Washington University in St. Louis, St. Louis, MO 63130, USA; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO 63130, USA.

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Cancer Cell. 2023 Aug 14;41(8):1397-1406. doi: 10.1016/j.ccell.2023.06.009.

DOI:10.1016/j.ccell.2023.06.009
PMID:37582339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10506762/
Abstract

The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) investigates tumors from a proteogenomic perspective, creating rich multi-omics datasets connecting genomic aberrations to cancer phenotypes. To facilitate pan-cancer investigations, we have generated harmonized genomic, transcriptomic, proteomic, and clinical data for >1000 tumors in 10 cohorts to create a cohesive and powerful dataset for scientific discovery. We outline efforts by the CPTAC pan-cancer working group in data harmonization, data dissemination, and computational resources for aiding biological discoveries. We also discuss challenges for multi-omics data integration and analysis, specifically the unique challenges of working with both nucleotide sequencing and mass spectrometry proteomics data.

摘要

美国国立癌症研究所的临床蛋白质组肿瘤分析联盟(CPTAC)从蛋白质基因组学的角度研究肿瘤,创建了丰富的多组学数据集,将基因组异常与癌症表型联系起来。为了促进泛癌研究,我们已经为 10 个队列中的 >1000 个肿瘤生成了协调的基因组、转录组、蛋白质组和临床数据,为科学发现创建了一个有凝聚力和强大的数据集。我们概述了 CPTAC 泛癌工作组在数据协调、数据传播和计算资源方面的努力,以帮助生物发现。我们还讨论了多组学数据集成和分析的挑战,特别是核苷酸测序和质谱蛋白质组学数据的独特挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/39d77ef6ef8b/nihms-1919526-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/9fd8c18baea4/nihms-1919526-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/42394ebb8a38/nihms-1919526-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/45d337c9a368/nihms-1919526-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/39d77ef6ef8b/nihms-1919526-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/9fd8c18baea4/nihms-1919526-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/42394ebb8a38/nihms-1919526-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/45d337c9a368/nihms-1919526-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed7e/10506762/39d77ef6ef8b/nihms-1919526-f0004.jpg

相似文献

1
Proteogenomic data and resources for pan-cancer analysis.泛癌分析的蛋白质基因组学数据和资源。
Cancer Cell. 2023 Aug 14;41(8):1397-1406. doi: 10.1016/j.ccell.2023.06.009.
2
A proteogenomics data-driven knowledge base of human cancer.一个基于人类癌症的蛋白质基因组学数据驱动的知识库。
Cell Syst. 2023 Sep 20;14(9):777-787.e5. doi: 10.1016/j.cels.2023.07.007. Epub 2023 Aug 23.
3
ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies.ProTrack:用于蛋白质基因组学研究的交互式多组学数据浏览器。
Proteomics. 2020 Nov;20(21-22):e1900359. doi: 10.1002/pmic.201900359. Epub 2020 Aug 6.
4
Simplified and Unified Access to Cancer Proteogenomic Data.简化和统一的癌症蛋白质基因组学数据访问。
J Proteome Res. 2021 Apr 2;20(4):1902-1910. doi: 10.1021/acs.jproteome.0c00919. Epub 2021 Feb 9.
5
Proteogenomic interrogation of cancer cell lines: an overview of the field.肿瘤细胞系的蛋白质基因组学研究:该领域概述。
Expert Rev Proteomics. 2021 Mar;18(3):221-232. doi: 10.1080/14789450.2021.1914594. Epub 2021 Apr 20.
6
Linking cancer genome to proteome: NCI's investment into proteogenomics.将癌症基因组与蛋白质组相联系:美国国立癌症研究所对蛋白质基因组学的投入。
Proteomics. 2014 Dec;14(23-24):2633-6. doi: 10.1002/pmic.201400193. Epub 2014 Oct 18.
7
A User-Friendly Visualization Tool for Multi-Omics Data.用于多组学数据的用户友好型可视化工具。
Proteomics. 2020 Nov;20(21-22):e2000136. doi: 10.1002/pmic.202000136. Epub 2020 Sep 3.
8
Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.CPTAC 蛋白质组学数据在 cBioPortal 癌症基因组学背景下的整合与分析。
Mol Cell Proteomics. 2019 Sep;18(9):1893-1898. doi: 10.1074/mcp.TIR119.001673. Epub 2019 Jul 15.
9
Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.癌症耐药性的蛋白质基因组学研究:迈向生物标志物发现与靶点鉴定
Expert Rev Proteomics. 2017 Apr;14(4):351-362. doi: 10.1080/14789450.2017.1299006. Epub 2017 Mar 6.
10
Computational identification of micro-structural variations and their proteogenomic consequences in cancer.计算鉴定癌症中的微观结构变化及其蛋白质基因组学后果。
Bioinformatics. 2018 May 15;34(10):1672-1681. doi: 10.1093/bioinformatics/btx807.

引用本文的文献

1
Multimodal integration strategies for clinical application in oncology.肿瘤学临床应用中的多模态整合策略
Front Pharmacol. 2025 Aug 20;16:1609079. doi: 10.3389/fphar.2025.1609079. eCollection 2025.
2
Pancancer outcome prediction via a unified weakly supervised deep learning model.通过统一的弱监督深度学习模型进行泛癌结果预测。
Signal Transduct Target Ther. 2025 Sep 3;10(1):285. doi: 10.1038/s41392-025-02374-w.
3
Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics.脑转移瘤中的免疫治疗生物标志物:对肿瘤微环境动态变化的见解

本文引用的文献

1
A proteogenomics data-driven knowledge base of human cancer.一个基于人类癌症的蛋白质基因组学数据驱动的知识库。
Cell Syst. 2023 Sep 20;14(9):777-787.e5. doi: 10.1016/j.cels.2023.07.007. Epub 2023 Aug 23.
2
PepQuery2 democratizes public MS proteomics data for rapid peptide searching. PepQuery2 使公共 MS 蛋白质组学数据民主化,便于快速进行肽搜索。
Nat Commun. 2023 Apr 18;14(1):2213. doi: 10.1038/s41467-023-37462-4.
3
Integrated proteogenomic characterization of medullary thyroid carcinoma.甲状腺髓样癌的综合蛋白质基因组特征分析
Front Immunol. 2025 Aug 13;16:1600261. doi: 10.3389/fimmu.2025.1600261. eCollection 2025.
4
Deep learning-driven multi-omics analysis: enhancing cancer diagnostics and therapeutics.深度学习驱动的多组学分析:增强癌症诊断与治疗
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf440.
5
DUSP9 is Up-Regulated and Promotes Tumor Progression in Head and Neck Squamous Cell Carcinoma.双特异性磷酸酶9(DUSP9)在头颈部鳞状细胞癌中上调并促进肿瘤进展。
J Cancer. 2025 Jul 24;16(11):3403-3414. doi: 10.7150/jca.110597. eCollection 2025.
6
A novel feedback loop between DYRK2 and USP28 regulates cancer homeostasis and DNA damage signaling.DYRK2和USP28之间的新型反馈回路调节癌症稳态和DNA损伤信号传导。
Cell Death Differ. 2025 Aug 26. doi: 10.1038/s41418-025-01565-w.
7
Functional characteristics of fresh antitumor immune interferer GDF-15 in multiple cancers.新型抗肿瘤免疫干扰因子GDF-15在多种癌症中的功能特性
Sci Rep. 2025 Aug 22;15(1):30864. doi: 10.1038/s41598-025-16737-4.
8
ChEA-KG: Human Transcription Factor Regulatory Network with a Knowledge Graph Interactive User Interface.ChEA知识图谱:具有知识图谱交互式用户界面的人类转录因子调控网络。
bioRxiv. 2025 Aug 12:2025.08.09.669505. doi: 10.1101/2025.08.09.669505.
9
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance.SHP2上的一个热点磷酸化位点驱动癌蛋白激活和耐药性。
Res Sq. 2025 Aug 5:rs.3.rs-7032881. doi: 10.21203/rs.3.rs-7032881/v1.
10
Development and validation of an integrative 54 biomarker-based risk identification model for multi-cancer in 42,666 individuals: a population-based prospective study to guide advanced screening strategies.基于54种生物标志物的综合多癌风险识别模型的开发与验证:一项针对42,666名个体的基于人群的前瞻性研究,以指导高级筛查策略
Biomark Res. 2025 Aug 11;13(1):101. doi: 10.1186/s40364-025-00812-z.
Cell Discov. 2022 Nov 8;8(1):120. doi: 10.1038/s41421-022-00479-y.
4
OmicsEV: a tool for comprehensive quality evaluation of omics data tables.OmicsEV:一种用于综合评估组学数据表质量的工具。
Bioinformatics. 2022 Dec 13;38(24):5463-5465. doi: 10.1093/bioinformatics/btac698.
5
Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.2002 例人类癌症的蛋白质基因组学特征分析揭示了泛癌分子亚型及相关途径。
Nat Commun. 2022 May 13;13(1):2669. doi: 10.1038/s41467-022-30342-3.
6
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.中国人群中肾透明细胞癌的蛋白质基因组分析
Nat Commun. 2022 Apr 19;13(1):2052. doi: 10.1038/s41467-022-29577-x.
7
Immunopeptidomic analyses of colorectal cancers with and without microsatellite instability.免疫肽组学分析微卫星不稳定与无微卫星不稳定结直肠肿瘤。
Mol Cell Proteomics. 2022 May;21(5):100228. doi: 10.1016/j.mcpro.2022.100228. Epub 2022 Apr 1.
8
Enhanced protein isoform characterization through long-read proteogenomics.通过长读蛋白质基因组学增强蛋白质亚型特征分析。
Genome Biol. 2022 Mar 3;23(1):69. doi: 10.1186/s13059-022-02624-y.
9
Cancer proteogenomics: current impact and future prospects.癌症蛋白质基因组学:当前影响与未来展望。
Nat Rev Cancer. 2022 May;22(5):298-313. doi: 10.1038/s41568-022-00446-5. Epub 2022 Mar 2.
10
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.多组学分析鉴定 CPT1A 为铂耐药性高级别浆液性卵巢癌的潜在治疗靶点。
Cell Rep Med. 2021 Dec 21;2(12):100471. doi: 10.1016/j.xcrm.2021.100471.